Shown verbatim: the complete text as captured from the official source posted by the New York State Senate, fetched 2026-08-11. Nothing is edited or removed. Where this bill amends existing law, language marked for deletion in the official source appears here in brackets. The official bill page.
S T A T E O F N E W Y O R K
________________________________________________________________________
5285
2025-2026 Regular Sessions
I N A S S E M B L Y
February 12, 2025
___________
Introduced by M. of A. REYES -- read once and referred to the Committee
on Higher Education
AN ACT to amend the education law and the public health law, in relation
to prescription labels for mifepristone and misoprostol
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Paragraph b-1 of subdivision 1 of section 6807 of the
education law, as added by a chapter of the laws of 2025 amending the
education law relating to the labeling of mifepristone, misoprostol, and
their generic alternatives, as proposed in legislative bills numbers S.
36-A and A. 2145-A, is amended to read as follows:
b-1. Notwithstanding paragraph b of this section, the prescription
label for mifepristone[,] OR misoprostol[, and their generic alterna-
tives] may include the name OR ADDRESS of the dispensing health care
practice instead of the name of the dispenser.
§ 2. Subdivision 1-a of section 6810 of the education law, as added by
a chapter of the laws of 2025 amending the education law relating to the
labeling of mifepristone, misoprostol, and their generic alternatives,
as proposed in legislative bills numbers S. 36-A and A. 2145-A, is
amended to read as follows:
1-a. Notwithstanding subdivision one of this section, at the
prescriber's request, the prescription label for mifepristone[,] OR
misoprostol[, and their generic alternatives may] SHALL include the name
OR ADDRESS of the prescribing health care practice instead of the name
of the prescriber.
§ 3. The public health law is amended by adding a new section 280-d to
read as follows:
§ 280-D. PATIENT NOTIFICATION OF PRESCRIPTION LABEL CHANGE. A HEALTH
CARE PRESCRIBER SHALL INFORM THE PATIENT IF SUCH PRESCRIBER HAS INCLUDED
OR HAS REQUESTED TO INCLUDE THE NAME OR ADDRESS OF THE PRESCRIBING
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD09082-01-5
A. 5285 2
HEALTH CARE PRACTICE INSTEAD OF THE NAME OF SUCH PRESCRIBER ON THE
PRESCRIPTION LABEL WHEN PRESCRIBING MIFEPRISTONE OR MISOPROSTOL.
§ 4. This act shall take effect on the same date and in the same
manner as a chapter of the laws of 2025 amending the education law
relating to the labeling of mifepristone, misoprostol, and their generic
alternatives, as proposed in legislative bills numbers S. 36-A and A.
2145-A, takes effect.Every fact on this page links to its source, starting with the official bill record.